Benefits of pravastatin extend to primary prevention of CHD Sean Henahan Newsletter Article 04 February 2013 Pages: 3 - 4
How early should inhaled corticosteroids be started in asthma? Newsletter Article 04 February 2013 Pages: 5 - 5
Clinical trials of tacrolimus tainted by conflicts of interest? Newsletter Article 04 February 2013 Pages: 5 - 5
Ticarcillin/clavulanic acid switch programme cost saving Newsletter Article 04 February 2013 Pages: 6 - 6
Smaller hospitals can ‘cost-justify’ antibacterial services Newsletter Article 04 February 2013 Pages: 7 - 7
Passive immunisation of mosquitoes may outwit malaria Newsletter Article 04 February 2013 Pages: 8 - 8
A promising particle-based gp160 immunogen for HIV vaccines Newsletter Article 04 February 2013 Pages: 8 - 8
Safer NSAIDs? Selective COX-2 inhibitors may be the answer David B Jack Newsletter Article 04 February 2013 Pages: 9 - 10
Pharmacokinetics of the metallo-endopeptidase inhibitor SCH-42354 Newsletter Article 04 February 2013 Pages: 10 - 10
Efficacy and safety of dexfenfluramine in obesity confirmed Newsletter Article 04 February 2013 Pages: 11 - 11
Thalidomide heals AIDS-related oral aphthous ulcers Newsletter Article 04 February 2013 Pages: 11 - 11
Anticonvulsant drug level monitoring often inappropriate Newsletter Article 04 February 2013 Pages: 11 - 11
Vigabatrin: first results in newly diagnosed patients Newsletter Article 04 February 2013 Pages: 12 - 12
Carbamazepine + MAOI may treat refractory depression Newsletter Article 04 February 2013 Pages: 12 - 12
Wide-ranging antiplatelet effects possible with abciximab Newsletter Article 04 February 2013 Pages: 12 - 12
Venlafaxine effective and well tolerated in chronic headache Newsletter Article 04 February 2013 Pages: 15 - 15
Timolol eye drops: systemic effects and interaction with oral quinidine Newsletter Article 04 February 2013 Pages: 18 - 18
Paracetamol enhances antiviral effect of low-dose interferon-α2a Newsletter Article 04 February 2013 Pages: 18 - 18
Transdermal estradiol patches have different bioavailability Newsletter Article 04 February 2013 Pages: 20 - 20
High-strength pancreatins clearly linked with fibrosing colonopathy Newsletter Article 04 February 2013 Pages: 21 - 21
Dexfenfluramine first antiobesity drug in US in 20 years Newsletter Article 04 February 2013 Pages: 22 - 22
Happenings in the New Zealand cardiovascular market Newsletter Article 04 February 2013 Pages: 22 - 22